W. Bell

Clinical and Biological Effects of Recombinant Human Interleukin-18 Administered by Intravenous Infusion to Patients with Advanced Cancer

Michael Atkins, William N. Bell, Henry Koon, 2006, Clinical Cancer Research.

A Dose-Escalation Study of Recombinant Human Interleukin-18 Using Two Different Schedules of Administration in Patients with Cancer

J. Kirkwood, L. Thurmond, M. Robertson, 2008, Clinical Cancer Research.

Differing effects of isoleucine deficiency on the toxicity of MNNG for 10T1/2 and CHO cells

D. Kaufman, J. Grisham, W. Bell, 1978, In Vitro.

Myelogenous Leukemia Cell Line RWLeu-4 on the Human Chronic 3 , 25-Dihydroxyvitamin D α Effects of 1 Updated

S. Lasky, R. Posner, M. Wiemann, 2006 .

Effects of 1 alpha, 25-dihydroxyvitamin D3 on the human chronic myelogenous leukemia cell line RWLeu-4.

S. Lasky, M. Posner, M. Wiemann, 1990, Cancer research.

Multicenter phase II study to evaluate a 28-day regimen of oral fluorouracil plus eniluracil in the treatment of patients with previously untreated metastatic colorectal cancer.

R. Schilsky, S. Mani, M. O'Rourke, 2000, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Randomized, open-label, phase III study of a 28-day oral regimen of eniluracil plus fluorouracil versus intravenous fluorouracil plus leucovorin as first-line therapy in patients with metastatic/advanced colorectal cancer.

R. Schilsky, R. Pazdur, M. Thirlwell, 2002, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Clonal analysis of the expression of multiple transformation phenotypes and tumorigenicity by morphologically transformed 10T1/2 cells.

J. Grisham, G. Smith, W. Bell, 1993, Cancer research.